financetom
Business
financetom
/
Business
/
Delhi excise policy case: ED arrests Aurobindo Pharma's Sarath Reddy, Pernod Ricard's Benoy Babu
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Delhi excise policy case: ED arrests Aurobindo Pharma's Sarath Reddy, Pernod Ricard's Benoy Babu
Nov 10, 2022 12:47 AM

The Enforcement Directorate arrested pharmaceutical firm Aurobindo Pharma's whole-time director, P Sarath Chandra Reddy, and multinational alcohol beverage company Pernod Ricard's General Manager-International Brands Benoy Babu on Thursday, sources told CNBC-TV18. Following raids at the duo's premises in Andhra Pradesh and Telangana, the agency's sources said the ED arrested them on money laundering charges, i.e. under sections of the Prevention of Money Laundering Act (PMLA).

As per BSE, P Sarath Chandra Reddy is the Executive Director of Aurobindo Pharma.

Earlier in October, ED raided at least 35 locations in Delhi, Punjab, in connection with the national capital's liquor excise policy case, while over 100 searches have already been conducted so far. The excise policy came under the scanner after Delhi Lieutenant Governor VK Saxena recommended a CBI probe.

Delhi Deputy Chief Minister Manish Sisodia is also an accused in an FIR registered by the Central Bureau of Investigation (CBI) in connection with alleged irregularities in the formulation and implementation of the Delhi Excise Policy 2021-22.

In October, the CBI questioned Sisodia in connection with alleged corruption in the formulation and implementation of the policy.

The ED also arrested Abhishek Boinpally, who was allegedly lobbying for certain liquor businessmen based in Southern India, on October 10. This was the second arrest in the excise scam case after businessman and Aam Aadmi Party leader Vijay Nair.

Meanwhile, a close aide of Delhi CM Sisodia will turn an approver in the excise policy case, the CBI informed a special court on November 7, a development which may be seen as a setback for the AAP leader ahead of Gujarat elections.

Special Judge M K Nagpal posted the matter to November 14 for arguments on the petition moved by the CBI and Dinesh Arora, a close aide of Sisodia, and decide whether to grant him pardon and allow him to turn an approver in the case.

According to the CBI FIR, Arora has been accused by the CBI of receiving a bribe of Rs 1 crore from a liquor manufacturer on behalf of Sisodia.

(Edited by : Kanishka Sarkar)

First Published:Nov 10, 2022 9:47 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PrairieSky Says Received TSX Approval for Renewed Normal Course Issuer Bid
PrairieSky Says Received TSX Approval for Renewed Normal Course Issuer Bid
May 30, 2025
08:38 AM EDT, 05/30/2025 (MT Newswires) -- PrairieSky Royalty Ltd. ( PREKF ) announced Friday that the Toronto Stock Exchange has accepted the notice of its intention to commence a normal course issuer bid. The company noted that on April 14, 2025, it announced its intention to seek TSX approval to renew its NCIB for an additional one-year period. The...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Mainstreet Equity Gets Approval for Stock Buyback
Mainstreet Equity Gets Approval for Stock Buyback
May 30, 2025
08:29 AM EDT, 05/30/2025 (MT Newswires) -- Mainstreet Equity ( MEQYF ) on Friday said the Toronto Stock Exchange has accepted its notice to buy back up to 475,359 shares for one year beginning on June 3. The company did not buy back any shares during its current normal course issuer bid, which ends on June 2. ...
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
May 30, 2025
Regeneron Pharmaceuticals ( REGN ), Inc. and Sanofi SA ( SNY ) on Friday announced results from two Phase 3 trials of itepekimab in chronic obstructive pulmonary disease (COPD) patients. Phase 3 AERIFY-1 trial evaluating itepekimab in adults who were former smokers with inadequately controlled COPD met the primary endpoint of significantly reducing moderate or severe acute exacerbations by 27% compared...
Copyright 2023-2026 - www.financetom.com All Rights Reserved